InMed Pharmaceuticals
Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a...
Read moreInvestor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a...
Read moreAstral Resources (AAR:AU) has announced Theia In-fill – Multiple High-Grade Zones of Gold Download the PDF here. This post appeared...
Read moreGreen Technology Metals(GT1:AU) has announced Ontario Lithium Project Development Update Download the PDF here. This post appeared first on investingnews.com
Read morePresident Donald Trump’s tariffs are hitting toy giants Mattel and Hasbro as the critical holiday season nears. Still, both companies...
Read moreThe gold price was back in action this week, breaking above the US$4,200 per ounce level after spending about two...
Read more